TY  - JOUR

T1  - Early Changes in Patient-Relevant Endpoints in Three Tralokinumab Pivotal Phase 3 Trials (ECZTRA 1−3) in Adult Patients with Moderate-to-Severe Atopic Dermatitis

JO  - SKIN The Journal of Cutaneous Medicine

PY  - 2020/10/27

AU  - Silverberg JI

AU  - Cork M

AU  - Wollenberg A

AU  - Katoh N

AU  - Steffensen LA

AU  - Kurbasic A

AU  - Olsen CK

AU  - Kuznetsova A

AU  - Østerdal ML

AU  - Vilsbøll AW

AU  - Deleuran M

ED  - 

DO  - DOI: 10.25251/skin.4.supp.98

PB  - National Society for Cutaneous Medicine

VL  - 4

IS  - 6

SP  - s98

EP  - s98

Y2  - 2024/12/22

ER  -